Cargando…

Vivo-Morpholino-Based Antiviral for SARS-CoV-2: Implications for Novel Therapies in the Treatment of Acute COVID-19 Disease

Therapeutic modalities designed specifically to inhibit COVID-19 infection and replication would limit progressive COVID-19-associated pulmonary disease in infected patients and prevent or limit systemic disease. If effective, antivirals could reduce viral transmission rates by reducing viral burden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hildreth, James E. K., Moulton, Jon D., Alcendor, Donald J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394971/ https://www.ncbi.nlm.nih.gov/pubmed/34440222 http://dx.doi.org/10.3390/biomedicines9081018

Ejemplares similares

Inhibition and Escape of SARS-CoV Treated with Antisense Morpholino Oligomers
por: Neuman, Benjamin W., et al.
Publicado: (2006)

Gene Knockdowns in Adult Animals: PPMOs and Vivo-Morpholinos
por: Moulton, Jon D., et al.
Publicado: (2009)

Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds
por: Nan, Yuchen, et al.
Publicado: (2018)

Advanced morpholino oligomers: A novel approach to antiviral therapy
por: Warren, Travis K., et al.
Publicado: (2012)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

SARS-CoV-2 Antiviral Therapy
por: Tao, Kaiming, et al.
Publicado: (2021)

In vivo Electroporation of Morpholinos into the Adult Zebrafish Retina
por: Thummel, Ryan, et al.
Publicado: (2011)

Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity
por: Hildreth, James E. K., et al.
Publicado: (2021)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

SARS-CoV-2 rebound with and without antivirals
por: Petrosillo, Nicola
Publicado: (2023)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Evaluation of In Vitro and In Vivo Antiviral Activities of Vitamin D for SARS-CoV-2 and Variants
por: Mok, Chee-Keng, et al.
Publicado: (2023)

Nitroreductase-Activatable Morpholino Oligonucleotides for in Vivo Gene Silencing
por: Yamazoe, Sayumi, et al.
Publicado: (2014)

Antiviral and Neuroprotective Role of Octaguanidinium Dendrimer-Conjugated Morpholino Oligomers in Japanese Encephalitis
por: Nazmi, Arshed, et al.
Publicado: (2010)

The discovery of antivirals and novel targets for SARS-CoV-2 and EV-A71
por: Haddad, Christina, et al.
Publicado: (2022)

In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age
por: Lieberman, Nicole A. P., et al.
Publicado: (2020)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment
por: Rebeaud, Mathieu E., et al.
Publicado: (2020)

Host proviral and antiviral factors for SARS-CoV-2
por: Lv, Lu, et al.
Publicado: (2021)

Mechanisms of Antiviral Immune Evasion of SARS-CoV-2
por: Beyer, Daniel K., et al.
Publicado: (2022)

Antiviral Effect of Budesonide against SARS-CoV-2
por: Heinen, Natalie, et al.
Publicado: (2021)

Theory and reality of antivirals against SARS-CoV-2
por: Zhao, Bo, et al.
Publicado: (2021)

Antiviral Efficacy of Pralatrexate against SARS-CoV-2
por: Bae, Joon-Yong, et al.
Publicado: (2021)

A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo
por: Day, Craig W., et al.
Publicado: (2009)

In vivo Electroporation of Morpholinos into the Regenerating Adult Zebrafish Tail Fin
por: Hyde, David R., et al.
Publicado: (2012)

Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target
por: Qin, Bo, et al.
Publicado: (2023)

Ayurvedic metal nanoparticles could be novel antiviral agents against SARS-CoV-2
por: Sarkar, Prasanta Kumar, et al.
Publicado: (2021)

An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection
por: Rosa, Luigi, et al.
Publicado: (2022)

Predicting In Vitro and In Vivo Anti-SARS-CoV-2 Activities of Antivirals by Intracellular Bioavailability and Biochemical Activity
por: Zhang, Jinwen, et al.
Publicado: (2022)

Targeted Inhibition of miRNA Maturation with Morpholinos Reveals a Role for miR-375 in Pancreatic Islet Development
por: Kloosterman, Wigard P, et al.
Publicado: (2007)

Novel and emerging mutations of SARS-CoV-2: Biomedical implications
por: Mohammadi, Elmira, et al.
Publicado: (2021)

Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19
por: Cho, Junhyung, et al.
Publicado: (2020)

The differential roles of zinc in immune responses and their potential implications in antiviral immunity against SARS-CoV-2
por: Reinhold, Dirk, et al.
Publicado: (2021)

Effective Dystrophin Restoration by a Novel Muscle-Homing Peptide-Morpholino Conjugate in Dystrophin-Deficient mdx Mice
por: Gao, Xianjun, et al.
Publicado: (2020)

Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV
por: Scroggs, Stacey L. P., et al.
Publicado: (2020)

Zika virus infection and implications for kidney disease
por: Alcendor, Donald J.
Publicado: (2018)

Potential Antiviral Options against SARS-CoV-2 Infection
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Potent antiviral effect of silver nanoparticles on SARS-CoV-2
por: Jeremiah, Sundararaj S., et al.
Publicado: (2020)

In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2020)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2lh1r8sivp4nimmregt0p1kk3d